Coya Therapeutics and Dr. Reddy's Partner To Treat ALS

Dr. Reddy's Laboratories SA and Coya Therapeutics, Inc. announced on that they have engaged into a research and license agreement for COYA 302, an investigational combination medication for the treatment of Amyotrophic Lateral Sclerosis (ALS)...

Indoco Remedies Bags US FDA Tentative Nod For Canagliflozin Tablets

Indoco Remedies Ltd. reported the receipt of a provisional US FDA approval for an Abbreviated New Drug Application (ANDA) for canagliflozin tablets 100 mg and 300 mg, a generic equivalent of Janssen Pharmaceuticals, Inc.'s Reference Listed Drug...

Venus Remedies Secures Marketing Approval For Three Oncology Drugs

Venus Remedies, a pharmaceutical company, announced that three oncology medications have been approved for marketing in the Philippines and Saudi Arabia. The Panchkula-based business said in a statement that it has acquired regulatory permission...

Sun Pharma Subsidiary and Aclaris Therapeutics Inks Licensing Pact

As per exchange filing, Sun Pharmaceutical Industries Inc., a subsidiary of India's leading medicine manufacturer Sun Pharma, has entered into a licensing arrangement with Aclaris Therapeutics Inc. Based on the licensing agreement, Aclaris has...

Clarivate Widens Alliance with VeriSIM Life For Drug Development

Clarivate Plc, a worldwide leader in connecting people and companies to trusted knowledge to alter their environment, has announced the debut of the VeriSIM Life Translational Index on Cortellis Drug Discovery knowledge by Clarivate. Customers...

Takeda and BIRAC Join Hands To Foster Healthcare Innovation

Takeda announced the signing of a three-year Memorandum of Understanding (MOU) with the Biotechnology Industry Research Assistance Council (BIRAC), a public-sector business established by the Government of India's Department of Biotechnology...

India-UK Research: Easy Test to Combat Antibiotic Resistance

A new India-UK research project is testing an easy-to-use urinary tract infection (UTI) test to help determine the appropriate course of action and tackle the global threat of antimicrobial resistance (AMR). According to the British Medical Research

China NMPA Approves Everest Medicine's Zetomipzomib IND for Immune

Everest Medicines, a biopharmaceutical company focused on the development, production and commercialization of innovative medicines and vaccines, announced that China's National Medical

Vesalius Pharma Seeks Indian Pharma Export to Colombo

Colombo-based pharmaceutical company Vesalius Pharma, headquartered in Bogotá, has invited Indian companies to export children's multivitamins and antifreeze powder, among others.

NCISM Announces Regulations for Medical Research

The National Commission for the Indian System of Medicine (NCISM) has announced regulations to set standards for medical research in the Indian System of Medicine (ISM).

© 2024 India Pharma Outlook. All Rights Reserved.